Despite the fact that BC is well known to be associated with metabolic characteristics of T2D, including hyperglycemia, hyperinsulinemia, inflammation, oxidative stress, and obesity, randomized controlled trials show opposite results for metformin as an insulin sensitizer [59]. Here, INS is linked to obesity disorder.